As per the research report, the size of the Asia Pacific Gynecology Surgical Instruments Market is valued at USD 0.44 billion in 2022 and estimated to grow at a CAGR of 7.2%, to reach USD 0.62 billion by 2027 during the forecast period 2022 to 2027.
The growing burden of chronic disease associated with the increasing female population is driving the APAC gynecology surgical instruments market in the years to come. In addition, other factors like the increased demand for better healthcare services, high healthcare spending in Asian countries and the rapidly growing number of gynecological surgeries are impacting this market.
According to latest statistics, in Japan, the average expenditure is about USD 36,100 on gynecological treatment per year. In 2019, Japanese families were reported to have spent around 78,500 yen on medical services.
High prevalence of various gynecological disorders like cancer of ovaries, cervix, uterus etc., PCOD, endometriosis, hysterectomy, tubectomy and endoscopy etc. is increasing the gynecological surgical instruments in APAC region.
According to the World Health Organization (WHO), cancer is the leading cause of death across the globe, with around 11 million deaths in 2020, according to the World Health Organization (WHO).
Based on a recent stud, it is reported that six in 100 women between the ages of 30 and 49, had been operated for hysterectomy in India. The prevalence is around 12 per 100 women in the 45-49 age group. Due to its large population, China accounted for 11.95% of cervical cancer deaths worldwide and 12.32% of cervical cancer in 2018. In South Korea, the incidence of cervical cancer was recorded to be 10.9 per 100,000 women, making cervical cancer as the seventh most common cancer among the Korean population.
In Asia-Pacific countries, with the increase in research and development and increased use of portable surgical instruments like laparoscopic procedures, is pushing this studied market towards a positive growth. In addition, there is also growing demand for minimally invasive surgical procedures and the latest products, which helps to increase a surgeon’s dexterity. All these aspects are anticipated are drive the growth of the APAC gynecology surgical instruments market.
However, lack of skilled professionals and increased preference for robotic surgeries are projected to slow the growth of the APAC gynecological surgical instruments market, while strict government regulation and inadequate reimbursement issues will challenge the market growth in the years to come.
This research report on the APAC Gynecology Surgical Instruments Market has been segmented and sub-segmented into the following categories.
By End User:
Geographically, Asia Pacific Gynecology Surgical Instruments Market is expected to reach at a significant rate and the growth can be linked to the increasing prevalence of gynecological diseases such as cancer, improved healthcare infrastructure.
The China Gynecology Surgical Instruments Market is predicted to be dominant region globally due to the high healthcare spending and adoption of technological advanced products, which are driving the growth of the market in this region.
The India Gynecology Surgical Instruments Market is expected to grow at a higher CAGR due to the increasing adoption of suitable instruments presence of the prominent female population.
The Australia Gynecology Surgical Instruments Market contributes to the considerable growth due to the increasing adoption of suitable instruments, prominent female population, increase in the number of gynecological disease and surgeries and growing awareness of minimally invasive surgical procedures.
In 2021, reported that 915 new cases of cervical cancer were diagnosed in Australia, according to canceraustralia.gov.au. In 2021, a woman is estimated to have 1 in 185 risk of being diagnosed with cervical cancer by the age of 85. In 2018, the incidence rate observed was 6.8 cases per 100,000 Australian women.
KEY MARKET PLAYERS
Top companies dominating in the APAC Gynecology Surgical Instruments Market profiled in the report are Olympus Corporation (Japan), B. Braun Melsungen AG (Germany), KARL STORZ GmbH & Co. KG (Germany), Richard WOLF GmbH (Germany), CooSklar Surgical Instruments (U.S.).,
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: firstname.lastname@example.org